BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home » Authors » Brady Huggett

Articles by Brady Huggett

Angry Merck Jurors Point To Public's Distaste For Pharma

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Ambit's $31M Series C Due To 'Tremendous' Technology

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Want To Make A Deal? Make Sure Potential Suitors Know Of Interest

Nov. 1, 2011
By Brady Huggett
VANCOUVER - Dating advice often counsels that the best way to get a date is to ask for one. The same could be said for biotechnology companies seeking pharmaceutical partnerships. It's possible that big pharma will get wind of a young company's science, approach and begin the partnering dance, but making the first move for biotechnology companies and being proactive can't hurt. (BioWorld Today)
Read More

Awaiting Aldurazyme Approval, BioMarin Files For Public Offering

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Religious Leaders Grab Horns Of Industry's Ethical Dilemmas

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Panacos' Stock Tumbles On Pushback Of HIV Phase III

Dec. 21, 2006
By Brady Huggett

Panacos' Stock Tumbles On Pushback Of HIV Phase III

Dec. 21, 2006
By Brady Huggett

OncoGenex Files For $48M IPO, Seeks Listings On Nasdaq, TSX

Dec. 14, 2006
By Jennifer Boggs and Brady Huggett

Previous Success Indicators Prove Shaky; Markets Wary

Nov. 13, 2006
By Brady Huggett

Previous Success Indicators Prove Shaky; Markets Wary

Nov. 13, 2006
By Brady Huggett
Previous 1 2 3 4 5 6 7 8 9 … 74 75 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing